1 – 18 of 18
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Loss of Chromosome Y in Neuroblastoma Is Associated With High-Risk Disease, 11q-Deletion, and Telomere Maintenance
(
- Contribution to journal › Article
-
Mark
Diagnostic yield and clinical impact of germline sequencing in children with CNS and extracranial solid tumors—a nationwide, prospective Swedish study
(
- Contribution to journal › Article
- 2023
-
Mark
The Swedish childhood tumor biobank : systematic collection and molecular characterization of all pediatric CNS and other solid tumors in Sweden
(
- Contribution to journal › Article
-
Mark
Diagnostic Yield From a Nationwide Implementation of Precision Medicine for all Children With Cancer
(
- Contribution to journal › Article
- 2022
-
Mark
The immune cell atlas of human neuroblastoma
(
- Contribution to journal › Article
-
Mark
A Phase II Trial of a Personalized, Dose-Intense Administration Schedule of 177Lutetium-DOTATATE in Children With Primary Refractory or Relapsed High-Risk Neuroblastoma–LuDO-N
(
- Contribution to journal › Article
-
Mark
Amplification of CDK4 and MDM2 : a detailed study of a high-risk neuroblastoma subgroup
(
- Contribution to journal › Article
- 2020
-
Mark
Integrative discovery of treatments for high-risk neuroblastoma
(
- Contribution to journal › Article
- 2019
-
Mark
Generation of induced pluripotent stem cell lines from two Neuroblastoma patients carrying a germline ALK R1275Q mutation
(
- Contribution to journal › Article
- 2018
-
Mark
Sense-Antisense lncRNA Pair Encoded by Locus 6p22.3 Determines Neuroblastoma Susceptibility via the USP36-CHD7-SOX9 Regulatory Axis
(
- Contribution to journal › Article
- 2015
-
Mark
Wnt/β-catenin pathway regulates MGMT gene expression in cancer and inhibition of Wnt signalling prevents chemoresistance.
(
- Contribution to journal › Article
- 2014
-
Mark
Emergence of New ALK Mutations at Relapse of Neuroblastoma.
(
- Contribution to journal › Article
- 2013
-
Mark
ERBB3 is a marker of a ganglioneuroblastoma/ganglioneuroma-like expression profile in neuroblastic tumours
(
- Contribution to journal › Article
-
Mark
MYC inhibition induces metabolic changes leading to accumulation of lipid droplets in tumor cells
(
- Contribution to journal › Article
- 2011
-
Mark
Detection of human cytomegalovirus in medulloblastomas reveals a potential therapeutic target
(
- Contribution to journal › Article
- 2008
-
Mark
Differentiation induced by physiological and pharmacological stimuli leads to increased antigenicity of human neuroblastoma cells
(
- Contribution to journal › Article
-
Mark
mRNAs of tyrosine hydroxylase and dopa decarboxylase but not of GD2 synthase are specific for neuroblastoma minimal disease and predicts outcome for children with high-risk disease when measured at diagnosis
(
- Contribution to journal › Article
- 2003
-
Mark
Noninvasive estimation of tumour viability in a xenograft model of human neuroblastoma with proton magnetic resonance spectroscopy (H-1 MRS)
(
- Contribution to journal › Article